Caffeine intake and the risk of chronic obstructive pulmonary disease in Japanese adults by Hirayama, Fumi et al.
This is a copy of an article published in the Journal of Caffeine 
Research; copyright © 2012 Mary Ann Liebert, Inc.; Journal of 
Caffeine Research is available online at: http://online.liebertpub.com 
 
Caffeine Intake and the Risk of Chronic Obstructive
Pulmonary Disease in Japanese Adults
Fumi Hirayama,1 Andy H. Lee,2 Keiji Yasukawa,1,3 Yukio Ishihara,1 and Masaki Shinjo4
Background: To investigate the association between caffeine intake and the risk of developing chronic obstructive
pulmonary disease (COPD) among Japanese older adults, a case–control study was conducted in central Japan.
Methods: A total of 277 patients with COPD aged 50 to 75 years were referred by respiratory physicians, while 340
controls were recruited from the community. All participants had their disease status confirmed by spirometry.
Information on habitual caffeine intake, demographic, and lifestyle characteristics was obtained by face-to-face
interview using a validated questionnaire.
Results: The COPD patients drank more coffee and had a higher mean caffeine intake (311.3, SD 176.2 mg/day)
than the control group (278.4, SD 188.1 mg/day), p = 0.03. Relative to nondrinkers, the risk of COPD apparently
increased for those drinking at least two cups of coffee daily (adjusted odds ratio 1.58, 95% confidence interval
[CI] 0.93 to 2.71). Similarly, total caffeine intake was associated with the prevalence of COPD—the adjusted
odds ratio being 1.30 (95% CI 1.09 to 2.12) for consuming over 312 mg/day when compared to a low intake of
less than 184 mg/day.
Conclusions: The epidemiological evidence suggested a positive association between caffeine intake and the de-
velopment of COPD in Japanese adults. Further study of the effect of caffeine on lung function and the risk of
COPD should be undertaken.
Introduction
Chronic obstructive pulmonary disease (COPD) is aleading cause of death and disability worldwide.1 It is
characterized by a progressive irreversible air flow limitation
with common symptoms that include chronic cough, sputum
production, and dyspnoea on exertion.2 Although tobacco
smoking is known to be the principal risk factor, 25% to
45% of patients with COPD have never smoked.2 Therefore,
dietary habits, environmental exposure, and other host fac-
tors may contribute to the development of this disease.3,4 In
Japan, the burden of COPD is expected to increase for the
next decade due to continue cigarette smoking and the
aging population.5 Research on the risk factors of COPD is
thus important for the control and prevention of this disease.
The effects of caffeine and/or coffee consumption on the re-
spiratory system have been inconsistent. A large population-
based cohort study in the USA found that nonsmokers who
drank at least four cups of coffee per day have slightly better
lung function than those who never or seldom drank coffee.6
It has also been suggested that caffeine can reduce respiratory
muscle fatigue and asthma symptoms.7 While caffeine appears
to have no deleterious effect on breathlessness,8 an experimen-
tal study showed that caffeine can stimulate the proliferation of
human lung adenocarcinoma cells and small airway epithelial
cells.9 Meta analyses further confirmed a significant positive
association between coffee consumption and the lung cancer
risk,10 with a linear dose–response relationship.11
Although caffeine ingestion has been suspected of contrib-
uting to the development of COPD,12 the hypothesis has
never been investigated in the literature. The objective of
this research was to ascertain the strength of association be-
tween caffeine intake and the prevalence of COPD, by con-
ducting a case–control study in Japan.
Materials and Methods
Participants
Three hundred COPD patients referred by respiratory phy-
sicians were recruited from the outpatient departments of six
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hospitals in central Japan (Aichi, Gifu, and Kyoto). Inclusion
criteria for cases were as follows: (1) aged between 50 and 75
years; (2) had COPD as the primary functionally limiting ill-
ness that was diagnosed within the past 3 years. Patients were
excluded if they had a recent stroke, dementia, or other health
conditions that prohibited them from being interviewed.
Twenty-three eligible patients were subsequently excluded
due to missing or incomplete demographic and lifestyle de-
tails. The remaining 277 patients (244 men and 33 women)
were available for analysis.
During the same period, 400 community-dwelling adults
were recruited from the same catchment areas as the cases.
These controls were approached and interviewed by the
first author at shopping malls, community centers, or when
they attended health checks at hospitals. They were selected
to be frequency-matched to the prevalent cases by age (within
5 years). The same exclusion criteria as cases were applied,
resulting in 340 eligible controls (272 men and 68 women).
All participants underwent spirometric measurements of re-
spiratory function to avoid misclassification of the case–
control status. No significant differences were found between
the included and excluded participants in terms of the avail-
able variables. Approval of the study protocol was obtained
from the Human Research Ethics Committee of Curtin Uni-
versity. Permission to recruit patients and access to medical
records were granted by the participating hospitals in Japan.
Questionnaire and interview
Information on habitual food and beverage consumption
was obtained using a food frequency questionnaire devel-
oped by the Japan Epidemiological Association,13 with valid-
ity and reproducibility being established for Japanese
adults.14 For each beverage type, such as coffee and green
tea, participants were asked to report the average quantity
consumed and frequency of intake in nine levels ranging
from ‘‘almost never’’ to ‘‘10 or more cups per day.’’ Chocolate
intake (g/day) was calculated by multiplying the frequency
with the portion size per time. The reference recall for dietary
variables was set at 5 years before interview because estima-
tion beyond 5 years would be difficult.
The final part of the structured questionnaire collected infor-
mation on demographic and lifestyle characteristics, including
age, gender, weight, height, marital status, education level,
smoking, alcohol drinking, as well as history of recent health
conditions (hypertension, ischemic stroke, diabetes mellitus,
depression, and cancer). For the COPD patients, each inter-
view was conducted after making appointment with their re-
spiratory physician. The purpose of the study was explained
to each participant before obtaining their formal written con-
sent. All interviews, averaging 40 minutes in duration, took
place in the hospital outpatient departments for COPD pa-
tients and their place of recruitment for controls.
Statistical analysis
For each subject, total caffeine intake (mg/day) was
obtained by adding the corresponding quantities from coffee,
black tea, green tea, oolong tea, and chocolate consumption.
One serving was defined as 140 g for coffee and black tea,
80 g for green tea, and 200 g for oolong tea. The caffeine con-
tents of these items were taken from the Japanese standard ta-
bles of food composition, with 0.6 mg/g for coffee, 0.3 mg/g
for black tea, 0.2 mg/g for green tea and oolong tea, and
0.125 mg/g for chocolate.15 A cup of coffee, for example,
was thus assumed to contain 84 mg of caffeine.
After comparing the case and control groups using chi-
square and t tests, unconditional logistic regression analyses
were performed to determine the association between the prev-
alence of COPD and coffee drinking frequency, coffee con-
sumption quantity, and total caffeine intake. The exposure
variables were categorized into three levels of increasing con-
sumption, with cut points of the categories corresponding to
approximate tertiles for the distribution of controls. Each
regression model accounted for the effects of age, gender,
body–mass index (BMI), smoking status (never smoker, former
smoker, current smoker), alcohol drinking (nondrinker, drink-
er), education (high school or below, college or university), and
presence of a health condition. These variables were considered
potential confounders from the literature. All statistical analy-
ses were undertaken using the SPSS package version 20.0.
Results
Table 1 presents the demographic and lifestyle characteris-
tics of the participants. The majority of them were male (83%)
and married (84%), with mean age about 66 years. For the
case group, 220 patients (80%) had their COPD diagnosed
within the past 2 years. The COPD patients were on average
1 year older and had lower BMI (5 years ago) than the control
subjects. They also appeared to be less educated and non–




Age: mean (SD), years 66.47 (6.75) 65.35 (5.49) 0.028
Body–mass index:
mean (SD), kg/m2
21.94 (3.09) 23.54 (2.94) < 0.001
Gender 0.007
Male 244 (88.1%) 272 (80.0%)
Female 33 (11.9%) 68 (20.0%)
Educationa < 0.001
High school or below 221 (80.4%) 213 (63.6%)
College or university 54 (19.6%) 122 (36.4%)
Marital statusa 0.881
Single or divorced 43 (15.6%) 54 (16.0%)
Married 233 (84.4%) 283 (84.0%)
Health conditiona,b 0.988
Absence 134 (48.7%) 164 (48.7%)
Presence 141 (51.3%) 173 (51.3%)
Smoking statusa < 0.001
Current smoker 62 (22.5%) 65 (19.2%)
Former smoker 207 (75.3%) 136 (40.1%)
Never smoker 6 (2.2%) 138 (40.7%)
Alcohol drinkinga,c 0.026
Nondrinker 119 (43.0%) 116 (34.2%)
Drinker 158 (57.0%) 223 (65.8%)
aMissing data present.
bRecent history of hypertension, ischemic stroke, diabetes mellitus,
depression, or cancer.
cNondrinker: less than once per month; drinker: at least once per
month.
COPD, chronic obstructive pulmonary disease.
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alcohol drinkers relative to their counterparts without the dis-
ease. A significantly higher proportion of former smokers
was observed among COPD patients than among controls.
Table 2 compares the caffeine intake between case and con-
trol subjects. Mean total caffeine intake was significantly
higher among the COPD patients (311.3, SD 176.2 mg/day)
than among the controls (278.4, SD 188.1 mg/day), which
might be attributed to the difference in coffee consumption
( p = 0.001) between the two groups (mean 247, SD 225 mL/
day versus mean 186, SD 222 mL/day, respectively).
Table 3 presents the logistic regression results. Apparent
increase in COPD risk was observed for frequent coffee drink-
ing of at least two cups or over 140 mL daily, when compared
to nondrinkers or those with low consumption less than
30 mL/day. Similarly, total caffeine intake was positively as-
sociated with the COPD prevalence; the linear dose–response
relationship remained significant ( p = 0.03) after accounting
for the effects of confounding variables.
Discussion
The present study provides the first report on the associa-
tion between caffeine intake and the risk of COPD. The Japa-
nese Food Safety Commission has recommended an upper
limit of caffeine intake at 400 mg/day for healthy adults.16
It should be remarked that 28% of our participants (34% of
cases and 23% of controls) had exceeded this limit.
Our results showed that both coffee consumption and caf-
feine intake are positively associated with the prevalence of
COPD. It has been hypothesized that caffeine contributes to
the development of chronic airflow obstruction and plays a
role in the genesis of bronchial cancer, despite its beneficial ef-
fect on bronchospasm.12 Emerging epidemiological evidence
has also suggested that high levels of coffee consumption
may increase the risk of lung cancer,10,11,17 possibly by stim-
ulating the proliferation of lung adenocarcinoma cells and
small airway epithelial cells.9 Therefore, the carcinogenic ef-
fect of caffeine may outweigh the potentially protective effect
of phytochemicals present in coffee.17 Since caffeine possesses
a variety of pharmacological effects, more research is needed
to understand the biological mechanism underlying the rela-
tionship between caffeine and the development of COPD.
The effects of confounding factors have been accounted for
in the logistic regression models. It should be remarked that
classifying individuals as either ‘‘drinker’’ or ‘‘nondrinker’’
has provided little information on their actual alcohol use.
Moreover, the relationship between caffeine and alcohol is
complex, and can be mediated by smoking status.18,19 For
our participants, caffeine intake and alcohol drinking were
moderately associated ( p = 0.04) with higher caffeine intake
by nondrinkers (312.9, SD 182.3 mg/day) than drinkers
(281.0, SD 183.2 mg/day), but the difference between non-
drinkers (327.0, SD 179.5 mg/day) and drinkers (279.3, SD
178.0 mg/day) was more prominent ( p = 0.02) among former
smokers.
In this study, the sample size of 617 subjects allowed suffi-
cient power for the multivariable analysis. A validated and re-
liable food frequency questionnaire for Japanese adults was
administered to obtain information on habitual food and bev-
erage consumption, without performing direct measurements
of plasma or urinary caffeine level. Another strength of the
study was that spirometric measurements were taken to en-
sure correct classification of the case–control status. All inter-
views and assessments were conducted by the same
investigator (first author) to eliminate inter-interviewer bias.
Several limitations should be taken into consideration. The
retrospective cross-sectional study design posed a major lim-
itation so that any cause–effect relationship could not be
established. The adverse effect of caffeine was not established
for COPD and all participants were blinded to the study hy-
pothesis, so that information bias was unlikely. Although
Table 2. Comparison of Caffeine Intake from Various
Sources Between Case and Control Groups
COPD (n = 277) Control (n = 340)
Caffeine sources Mean (SD), mg/day Mean (SD), mg/day p
Coffee 148.22 (135.23) 111.89 (133.35) 0.001
Black tea 2.89 (10.74) 3.84 (11.65) 0.299
Green tea 136.12 (111.05) 139.93 (119.52) 0.690
Oolong tea 24.81 (66.51) 23.79 (67.36) 0.851
Chocolate 0.24 (0.60) 0.26 (0.60) 0.595
Total intake 311.33 (176.19) 278.39 (188.06) 0.030
COPD, chronic obstructive pulmonary disease.
Table 3. Coffee Consumption, Caffeine Intake, and Risk of COPD for Japanese Adults
Variable COPD Control Crude OR (95% CI) Adjusted ORa (95% CI) pa
Coffee drinking frequency 0.08
Never 51 (18.4%) 87 (26.0%) 1 1
1–2 times per week to 1 cup daily 103 (37.2%) 142 (42.4%) 1.24 (0.81, 1.90) 1.19 (0.70, 2.03)
2 or more cups daily 123 (44.4%) 106 (31.6%) 1.98 (1.29, 3.05) 1.58 (0.93, 2.71)
Coffee consumption quantity (mL/day) 0.04
< 30 68 (24.5%) 114 (34.0%) 1 1
30 to 140 86 (31.0%) 115 (34.3%) 1.25 (0.83, 1.89) 1.37 (0.82, 2.28)
> 140 123 (44.4%) 106 (31.6%) 1.95 (1.31, 2.89) 1.68 (1.02, 2.75)
Total caffeine intake (mg/day)
< 184 77 (28.5%) 112 (33.9%) 1 1 0.03
184 to 312 62 (23.0%) 106 (32.1%) 0.85 (0.56, 1.30) 0.66 (0.39, 1.13)
> 312 131 (48.5%) 112 (33.9%) 1.70 (1.16, 2.50) 1.30 (1.09, 2.12)
aAdjusted for age, gender, body–mass index, health condition (absence, presence), education (high school or below, college or university),
smoking status (current smoker, former smoker, never smoker), and alcohol drinking (nondrinker, drinker).
CI, confidence interval; OR, odds ratio.
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recall error could not be eliminated, face-to-face interviews
were conducted to help the recall of food and beverage con-
sumption and to avoid misinterpretation of the questions.
The community-dwelling controls were recruited during the
same period and from the same catchment area as the
cases. They should be representative of the elderly Japanese
population. However, the inherent selection bias still existed
because of their voluntary participation in the study. Reverse
causation was a possibility even though the reference time
point for dietary intake was set at 5 years before interview,
and no participant admitted any change in dietary habits
within the past 5 years. For this sample of participants, signif-
icant differences in demographic variables were observed
between case and control groups, but over-matching of
demographic characteristics could lead to recruitment diffi-
culty if many potential controls were deemed ineligible.
Finally, we noted the small effect sizes (< 0.3) despite the sta-
tistically significant differences in mean coffee consumption
and mean caffeine intake between the two groups.
Conclusions
This case–control study suggested that Japanese adults
with a high caffeine intake are susceptible to an increased
risk of COPD. Further replications in other populations and
large prospective cohort studies are recommended to confirm
the effect of caffeine intake on the development of COPD.
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